_flu-season-covid-19-and-vaccine-fatigue-preview-1.jpg "Flu season, COVID-19 and vaccine fatigue from season covid 19 Video Screenshot Preview 1")
Gallery_flu-season-covid-19-and-vaccine-fatigue-preview-3.jpg "Flu season, COVID-19 and vaccine fatigue from season covid 19 Video Screenshot Preview 3")
Gallery_flu-season-covid-19-and-vaccine-fatigue-preview-hqdefault.jpg "Flu season, COVID-19 and vaccine fatigue from season covid 19 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 56 seconds
👁 View: 723 times
Play Audio:👁 View: 723 times
Description:
KXAN
KXAN
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_how-covid-19-pandemic-precautions-crushed-the-flu-season.webp "Global News")
_us-states-battle-new-covid-19-surge-as-flu-season-starts.webp "Al Jazeera English")
_evidence-medication-could-benefit-long-covid-sufferers.webp "Evidence is mounting a medication already used to treat opioid and alcohol dependence, could benefit people living with long covid. Queensland researchers have published world-first findings showing naltrexone restores the function of impaired cells from patients with the debilitating condition.")
_overlap-of-covid-19-and-flu-season-could-have-devastating-consequences-124-nbc-nightly-news.webp "NBC News")
⏲ 2 minutes 18 seconds 👁 41.4K
_astrazeneca-requests-european-authorisation-of-covid-vaccine-be-pulled.webp "AstraZeneca was the first pharmaceutical laboratory to launch a vaccine on the market at the end of 2020, a year after the appearance of the virus.")
_flu-season-covid-19-and-vaccine-fatigue.webp "KXAN")
_covid-19-and-flu-set-to-peak-over-holiday-season-in-ontario-moore-urges-vaccinations.webp "CP24")
⏲ 4 minutes 3 seconds 👁 1.4K
_novavax-and-sanofi-strike-multi-billion-dollar-deal-for-co-commercialization-of-covid-19-vaccine.webp "Novavax has signed a multi-billion dollar deal with French drugmaker Sanofi to co-commercialize Novavax's protein-based COVID-19 vaccine starting in 2025. Sanofi will pay Novavax an upfront payment of $500 million and up to $700 million in additional payments based on development, regulatory, and launch milestones. Sanofi will also take a less than 5% equity stake in Novavax and provide royalty payments on future vaccine sales. The deal allows Sanofi to develop combination shots using Novavax's COVID vaccine with Sanofi's flu shot or other vaccines in its portfolio.")
⏲ 0:45 👁 515K
_how-covid-19-pandemic-precautions-crushed-the-flu-season.jpg)
_us-states-battle-new-covid-19-surge-as-flu-season-starts.jpg)
_evidence-medication-could-benefit-long-covid-sufferers.jpg)
_overlap-of-covid-19-and-flu-season-could-have-devastating-consequences-124-nbc-nightly-news.jpg)
_astrazeneca-requests-european-authorisation-of-covid-vaccine-be-pulled.jpg)
_flu-season-covid-19-and-vaccine-fatigue.jpg)
_covid-19-and-flu-set-to-peak-over-holiday-season-in-ontario-moore-urges-vaccinations.jpg)
_novavax-and-sanofi-strike-multi-billion-dollar-deal-for-co-commercialization-of-covid-19-vaccine.jpg)
![[+]](/images/menu.gif){kind=small}